Technical Analysis for MYO - Myomo Inc.

Grade Last Price % Change Price Change
D 10.15 -2.22% -0.23
MYO closed down 2.22 percent on Friday, April 16, 2021, on 63 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical MYO trend table...

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
Multiple of Ten Bullish Other 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Lower Bollinger Band Walk Weakness -2.22%
Older End-of-Day Signals for MYO ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Rose Above Lower Bollinger Band about 10 hours ago
2x Volume Pace about 10 hours ago
1.5x Volume Pace about 10 hours ago
Down 5% about 10 hours ago
Down 3% about 10 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Myomo Inc. Description

Myomo, Inc. is a commercial stage medical robotics Company that offers expanded mobility for those suffering from neurological disorders and upper limb paralysis. Based on patented technology developed at MIT and the Company, Myomo develops and markets the MyoPro® product line of lightweight, non-invasive, powered arm braces to restore function in the paralyzed or weakened arms and hands of individuals that have suffered a stroke, spinal cord or nerve injury such as brachial plexus injury, or other neuromuscular disability such as amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS). It is provided through clinical relationships with VA medical centers, leading rehabilitation hospitals, and Orthotics and Prosthetics (“O&P”) practices. Several hundred have been successfully used by patients. It is the only device that, sensing a patient’s own neurological signals through non-invasive sensors on the arm, can restore their ability to use their arms and hands so that they can return to work, live independently and reduce their cost of care. Myomo is headquartered in Cambridge, Massachusetts, with sales and clinical professionals across the U.S. For more information, please visit


Sector: Healthcare
Industry: Medical Devices
Keywords: Organ Systems Disability Injury Robotics Neurological Disorders Multiple Sclerosis Stroke Prosthetics Nerve Amyotrophic Lateral Sclerosis Urological Disorders Orthopedics Spinal Cord Podiatry Lexus Neurotrauma Skeletal System Orthotics

Is MYO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 18.88
52 Week Low 3.42
Average Volume 180,169
200-Day Moving Average 7.40
50-Day Moving Average 12.97
20-Day Moving Average 12.39
10-Day Moving Average 11.60
Average True Range 1.00
ADX 19.69
+DI 11.09
-DI 30.00
Chandelier Exit (Long, 3 ATRs ) 11.50
Chandelier Exit (Short, 3 ATRs ) 12.61
Upper Bollinger Band 14.53
Lower Bollinger Band 10.26
Percent B (%b) -0.02
BandWidth 34.50
MACD Line -0.61
MACD Signal Line -0.30
MACD Histogram -0.3113
Fundamentals Value
Market Cap 46.51 Million
Num Shares 4.58 Million
EPS -0.74
Price-to-Earnings (P/E) Ratio -13.75
Price-to-Sales 3.13
Price-to-Book 2.53
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.56
Resistance 3 (R3) 11.54 11.04 11.33
Resistance 2 (R2) 11.04 10.68 11.06 11.25
Resistance 1 (R1) 10.60 10.46 10.35 10.62 11.17
Pivot Point 10.10 10.10 9.98 10.12 10.10
Support 1 (S1) 9.66 9.74 9.41 9.68 9.13
Support 2 (S2) 9.16 9.52 9.18 9.05
Support 3 (S3) 8.72 9.16 8.98
Support 4 (S4) 8.74